Lung Small Cell Carcinoma, I Subtype
specificA molecular subtype of lung small cell carcinoma characterized by the overexpression of achaete-scute homolog 1 (ASCL1) transcription factor. It is associated with high expression of neuroendocrine markers and classic morphology.
15
Centers
15
Active Trials
—
Cancer Funding
Top Centers for Lung Small Cell Carcinoma, I Subtype(15)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | NCI Comprehensive Active Research Program | 53.3 |
| 2 | NCI Comprehensive Active Research Program | 53.3 |
| 3 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 53.3 |
| 4 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 53.3 |
| 5 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 53.3 |
| 6 | NCI Clinical Active Research Program | 53.3 |
| 7 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program | 53.3 |
| 8 | Wilmot Cancer Institute, UR MedicineRochester, NY NCI Clinical Active Research Program | 53.3 |
| 9 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 53.3 |
| 10 | University of Illinois Cancer CenterChicago, IL Active Research Program | 53.3 |
| 11 | Boston University Cancer CenterBoston, MA Active Research Program | 53.3 |
| 12 | Active Research Program | 53.3 |
| 13 | Cancer Center at IllinoisUrbana, IL Active Research Program | 53.3 |
| 14 | Stony Brook Cancer CenterStony Brook, NY Active Research Program | 53.3 |
| 15 | Loma Linda University Cancer CenterLoma Linda, CA Active Research Program | 53.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →